Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1990 1
1994 2
1995 1
1997 2
1998 5
1999 2
2000 1
2002 2
2004 1
2005 3
2006 2
2007 3
2008 8
2009 7
2010 4
2011 2
2012 14
2013 7
2014 16
2015 13
2016 11
2017 16
2018 16
2019 13
2020 15
2021 18
2022 24
2023 15
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries.
Heyland DK, Wibbenmeyer L, Pollack J, Friedman B, Turgeon AF, Eshraghi N, Jeschke MG, Bélisle S, Grau D, Mandell S, Velamuri SR, Hundeshagen G, Moiemen N, Shokrollahi K, Foster K, Huss F, Collins D, Savetamal A, Gurney JM, Depetris N, Stoppe C, Ortiz-Reyes L, Garrel D, Day AG; RE-ENERGIZE Trial Team. Heyland DK, et al. N Engl J Med. 2022 Sep 15;387(11):1001-1010. doi: 10.1056/NEJMoa2203364. Epub 2022 Sep 9. N Engl J Med. 2022. PMID: 36082909 Clinical Trial.
The median time to discharge alive from the hospital was 40 days (interquartile range, 24 to 87) in the glutamine group and 38 days (interquartile range, 22 to 75) in the placebo group (subdistribution hazard ratio for discharge alive, 0.91; 95% confidence interval [CI], 0.80 to …
The median time to discharge alive from the hospital was 40 days (interquartile range, 24 to 87) in the glutamine group and 38 days (interqu …
Aspirin in patients undergoing noncardiac surgery.
Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MT, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Gao P, Pogue J, Whitlock R, Lamy A, Kearon C, Baigent C, Chow C, Pettit S, Chrolavicius S, Yusuf S; POISE-2 Investigators. Devereaux PJ, et al. N Engl J Med. 2014 Apr 17;370(16):1494-503. doi: 10.1056/NEJMoa1401105. Epub 2014 Mar 31. N Engl J Med. 2014. PMID: 24679062 Free article. Clinical Trial.
RESULTS: The primary outcome occurred in 351 of 4998 patients (7.0%) in the aspirin group and in 355 of 5012 patients (7.1%) in the placebo group (hazard ratio in the aspirin group, 0.99; 95% confidence interval [CI], 0.86 to 1.15; P=0.92). Major bleeding was more common i …
RESULTS: The primary outcome occurred in 351 of 4998 patients (7.0%) in the aspirin group and in 355 of 5012 patients (7.1%) in the placebo …
A comparison between the effects of ginger, pyridoxine (vitamin B6) and placebo for the treatment of the first trimester nausea and vomiting of pregnancy (NVP).
Sharifzadeh F, Kashanian M, Koohpayehzadeh J, Rezaian F, Sheikhansari N, Eshraghi N. Sharifzadeh F, et al. J Matern Fetal Neonatal Med. 2018 Oct;31(19):2509-2514. doi: 10.1080/14767058.2017.1344965. Epub 2017 Jul 7. J Matern Fetal Neonatal Med. 2018. PMID: 28629250 Clinical Trial.

Total score of Rhodes questionnaire for nausea was decreased significantly in three groups after treatment. (p < .001, p = .012, and p = .03 for ginger, vitamin B6, and placebo, respectively.) ...Ginger and vitamin B6 were more effective than placebo (p

Total score of Rhodes questionnaire for nausea was decreased significantly in three groups after treatment. (p < .001, p =

QT interval and P wave dispersion in slow coronary flow phenomenon.
Eshraghi A, Hoseinjani E, Jalalyazdi M, Vojdanparast M, Jafarzadeh-Esfehani R. Eshraghi A, et al. ARYA Atheroscler. 2018 Sep;14(5):212-217. doi: 10.22122/arya.v14i5.1599. ARYA Atheroscler. 2018. PMID: 30783411 Free PMC article.

RESULTS: QT-interval [76.17 (35.23) ms versus 39.25 (19.26) ms] and P-wave [39.74 (17.48) ms versus 19.50 (8.54) ms] dispersion were significantly higher among patients with SCF phenomenon (P < 0.050). In addition, there was a positive significant linear correlat

RESULTS: QT-interval [76.17 (35.23) ms versus 39.25 (19.26) ms] and P-wave [39.74 (17.48) ms versus 19.50 (8.54) ms] dispersion were …
Cerebroplacental ratio (CPR) and reduced fetal movement: predicting neonatal outcomes.
Eshraghi N, Jamal A, Eshraghi N, Kashanian M, Sheikhansari N. Eshraghi N, et al. J Matern Fetal Neonatal Med. 2022 May;35(10):1923-1928. doi: 10.1080/14767058.2020.1774544. Epub 2020 Jun 4. J Matern Fetal Neonatal Med. 2022. PMID: 32495705

RESULTS: The RFM group had significantly higher UA- PI MoM (1.01 0.19 versus 0.86 0.05, p < .001), lower MCA MoM (1.28 0.20 versus 1.40 0.13, (p < .001)) and lower CPR MoM (0.98 0.24 versus 1.23 0.12, (p < .001)) compared to the control group. ...In

RESULTS: The RFM group had significantly higher UA- PI MoM (1.01 0.19 versus 0.86 0.05, p < .001), lower MCA MoM (1.28 0.20 versus

Stable Thermally-Modulated Nanodroplet Ultrasound Contrast Agents.
Vasiukhina A, Eshraghi J, Ahmadzadegan A, Goergen CJ, Vlachos PP, Solorio L. Vasiukhina A, et al. Nanomaterials (Basel). 2021 Aug 29;11(9):2225. doi: 10.3390/nano11092225. Nanomaterials (Basel). 2021. PMID: 34578541 Free PMC article.
Once activated, the particles maintained their enhanced echogenicity (p < 0.001) for at least 13 h while retaining their nanoscale size. ...

Once activated, the particles maintained their enhanced echogenicity (p < 0.001) for at least 13 h while retaining their nanoscale

Business practices efficiency: Impact of integrating digital technology on clinical P&O practices.
Eshraghi A, Phillips C, Heim W. Eshraghi A, et al. Prosthet Orthot Int. 2023 Dec 1;47(6):621-624. doi: 10.1097/PXR.0000000000000249. Epub 2023 Jun 28. Prosthet Orthot Int. 2023. PMID: 37395754
This professional opinion article discusses the ways that AM has changed P&O services, with a specific focus on prosthetic socket manufacturing. Digitalizing P&O services will eventually change the business model used in clinics, which is further explored he …
This professional opinion article discusses the ways that AM has changed P&O services, with a specific focus on prosthetic socket …
Echocardiographic and electrocardiographic findings in COVID-19 patients: a cross-sectional study.
Keihanian F, Poorzand H, Saeidinia A, Eshraghi A. Keihanian F, et al. Int J Cardiovasc Imaging. 2022 Oct;38(10):2167-2175. doi: 10.1007/s10554-022-02617-9. Epub 2022 Apr 26. Int J Cardiovasc Imaging. 2022. PMID: 37726458 Free PMC article.

Multivariate analysis showed that O2 saturation at admission was independently a predictor of re-hospitalization (P < 0.001). RV size (P < 0.001), dyslipidemia (P < 0.001), ejection fraction (EF) (P < 0.001), age (P = 0.020), systoli

Multivariate analysis showed that O2 saturation at admission was independently a predictor of re-hospitalization (P < 0.001). RV s

Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study.
COVIDSurg Collaborative; GlobalSurg Collaborative. COVIDSurg Collaborative, et al. Anaesthesia. 2021 Nov;76(11):1454-1464. doi: 10.1111/anae.15560. Epub 2021 Aug 9. Anaesthesia. 2021. PMID: 34371522 Free article. Clinical Trial.
Although the overall rates of postoperative pulmonary complications were similar in those that isolated and those that did not (2.1% vs 2.0%, respectively), isolation was associated with higher rates of postoperative pulmonary complications after adjustment (adjusted OR 1.20, 95% …
Although the overall rates of postoperative pulmonary complications were similar in those that isolated and those that did not (2.1% vs 2.0% …
215 results